These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28453910)

  • 1. Central nervous system disease in pediatric acute myeloid leukemia: A report from the Children's Oncology Group.
    Johnston DL; Alonzo TA; Gerbing RB; Aplenc R; Woods WG; Meshinchi S; Gamis AS
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28453910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture.
    Bürger B; Zimmermann M; Mann G; Kühl J; Löning L; Riehm H; Reiter A; Schrappe M
    J Clin Oncol; 2003 Jan; 21(2):184-8. PubMed ID: 12525508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.
    Winick N; Devidas M; Chen S; Maloney K; Larsen E; Mattano L; Borowitz MJ; Carroll A; Gastier-Foster JM; Heerema NA; Willman C; Wood B; Loh ML; Raetz E; Hunger SP; Carroll WL
    J Clin Oncol; 2017 Aug; 35(22):2527-2534. PubMed ID: 28535084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study.
    Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
    Pediatr Blood Cancer; 2010 Sep; 55(3):414-20. PubMed ID: 20658610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal dose intensification by CNS status at diagnosis in the treatment of children with acute lymphoblastic leukemia.
    Jastaniah W; Elimam N; Abdalla K; AlAzmi AA; Algamal A; Felimban S
    Hematology; 2019 Dec; 24(1):369-377. PubMed ID: 30885098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the early intensification of intrathecal therapy improve outcomes in pediatric acute lymphoblastic leukemia patients with CNS2/TLP+ status at diagnosis?
    Jastaniah W; Elimam N; Abdalla K; Khattab TM; Felimban S; Abrar MB
    Hematology; 2015 Dec; 20(10):561-6. PubMed ID: 26010408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of central nervous system involvement at diagnosis of pediatric acute myeloid leukemia: a single institution's experience.
    Abbott BL; Rubnitz JE; Tong X; Srivastava DK; Pui CH; Ribeiro RC; Razzouk BI
    Leukemia; 2003 Nov; 17(11):2090-6. PubMed ID: 14523477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and early treatment response of central nervous system involvement in childhood acute lymphoblastic leukemia.
    Levinsen M; Taskinen M; Abrahamsson J; Forestier E; Frandsen TL; Harila-Saari A; Heyman M; Jonsson OG; Lähteenmäki PM; Lausen B; Vaitkevičienė G; Asberg A; Schmiegelow K;
    Pediatr Blood Cancer; 2014 Aug; 61(8):1416-21. PubMed ID: 24623619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of blasts in the cerebrospinal fluid without pleiocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: experience of the Dutch Childhood Oncology Group.
    ; te Loo DM; Kamps WA; van der Does-van den Berg A; van Wering ER; de Graaf SS
    J Clin Oncol; 2006 May; 24(15):2332-6. PubMed ID: 16710032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superior outcome of pediatric acute myeloid leukemia patients with orbital and CNS myeloid sarcoma: a report from the Children's Oncology Group.
    Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
    Pediatr Blood Cancer; 2012 Apr; 58(4):519-24. PubMed ID: 21618422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system involvement at presentation in childhood acute lymphoblastic leukemia: management experience and lessons.
    Marwaha RK; Kulkarni KP; Bansal D; Trehan A
    Leuk Lymphoma; 2010 Feb; 51(2):261-8. PubMed ID: 20038226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome.
    Del Principe MI; Buccisano F; Soddu S; Maurillo L; Cefalo M; Piciocchi A; Consalvo MI; Paterno G; Sarlo C; De Bellis E; Zizzari A; De Angelis G; Fraboni D; Divona M; Voso MT; Sconocchia G; Del Poeta G; Lo-Coco F; Arcese W; Amadori S; Venditti A
    Semin Hematol; 2018 Oct; 55(4):209-214. PubMed ID: 30502849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: a Childrens Cancer Group report.
    Gilchrist GS; Tubergen DG; Sather HN; Coccia PF; O'Brien RT; Waskerwitz MJ; Hammond GD
    J Clin Oncol; 1994 Dec; 12(12):2594-600. PubMed ID: 7989934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Myeloid Leukemia With Central Nervous System Involvement in Children: Experience From the French Protocol Analysis ELAM02.
    Felix A; Leblanc T; Petit A; Nelkem B; Bertrand Y; Gandemer V; Sirvent A; Paillard C; Schmitt C; Rohrlich PS; Fenneteau O; Ragu C; Michel G; Auvrignon A; Baruchel A; Leverger G
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):43-47. PubMed ID: 29189507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose methotrexate vs. Capizzi methotrexate for the treatment of childhood T-cell acute lymphoblastic leukemia.
    Jastaniah W; Elimam N; Abdalla K; AlAzmi AA; Aseeri M; Felimban S
    Leuk Res Rep; 2018; 10():44-51. PubMed ID: 30416957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.
    Laszlo GS; Alonzo TA; Gudgeon CJ; Harrington KH; Gerbing RB; Wang YC; Ries RE; Raimondi SC; Hirsch BA; Gamis AS; Meshinchi S; Walter RB
    Clin Cancer Res; 2015 Jul; 21(14):3187-95. PubMed ID: 25825478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic significance of cerebrospinal fluid flow cytometry in Chinese children with B lineage acute lymphoblastic leukemia.
    Tang X; Mai H; Wang L; Chen S; Chen F; Li T; Liu Y; Zhou G; Liu S; Wang Y; Liu S; Fu X; Wen F
    BMC Pediatr; 2024 Mar; 24(1):204. PubMed ID: 38519960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group report.
    Gossai NP; Devidas M; Chen Z; Wood BL; Zweidler-McKay PA; Rabin KR; Loh ML; Raetz EA; Winick NJ; Burke MJ; Carroll AJ; Esiashvili N; Heerema NA; Carroll WL; Hunger SP; Dunsmore KP; Winter SS; Teachey DT
    Blood; 2023 Apr; 141(15):1802-1811. PubMed ID: 36603187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531.
    Pollard JA; Loken M; Gerbing RB; Raimondi SC; Hirsch BA; Aplenc R; Bernstein ID; Gamis AS; Alonzo TA; Meshinchi S
    J Clin Oncol; 2016 Mar; 34(7):747-55. PubMed ID: 26786921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.